Goldman Sachs’s Agilon Health AGL Stock Holding History

Goldman Sachs’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,380	Closed	-$65.5K	–	6034
2024 Q4	$65.5K	Hold	1,380	–	–	﹤0.01%	5823
2024 Q3	$136K	Hold	1,380	–	–	﹤0.01%	5535
2024 Q2	$226K	Hold	1,380	–	–	﹤0.01%	5211
2024 Q1	$210K	Sell	1,380 -2,600	-65%	-$433K	﹤0.01%	5096
2023 Q4	$1.25M	Hold	3,980	–	–	﹤0.01%	4259
2023 Q3	$1.77M	Hold	3,980	–	–	﹤0.01%	3865
2023 Q2	$1.73M	Buy	3,980 +1,380	+53%	+$776K	﹤0.01%	3977
2023 Q1	$1.54M	Buy	+2,600	New	+$1.46M	﹤0.01%	4056

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Goldman Sachs's AGL Position: Q2 2026 in Review

Goldman Sachs reduced its Agilon Health (AGL) stake by 35% in Q2 2026, selling an estimated $24.6M and leaving 686,792 shares worth $73.6M. The position accounts for 0.01% of the portfolio, ranked #1468.

Goldman Sachs first reported a position in AGL in Q3 2021 and has held it in 20 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Goldman Sachs held 686,792 shares of Agilon Health worth $73.6M as of Q2 2026.
Goldman Sachs sold 375,444 Agilon Health shares in Q2 2026, an estimated $24.6M.
Agilon Health made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1468 holding.
Goldman Sachs first reported a position in Agilon Health in Q3 2021 and has held it in 20 quarters since.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.